Chemoprotective 3H-1,2-dithiole-3-thione induces antioxidant genes in vivo

M A Otieno1, T W Kensler, K Z Guyton

  • 1Department of Environmental Health Sciences, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

Insights

3H-1,2-dithiole-3-thione (D3T) significantly boosts antioxidant enzymes like catalase and manganese superoxide dismutase (MnSOD) in rats. This induction of key detoxifying genes may explain the cancer-protective effects of D3T.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Toxicology

Background:

  • 1,2-dithiole-3-thiones are known for inhibiting chemically induced tumors.
  • While enzyme induction is a known mechanism, other pathways for chemoprotection are suspected.

Purpose of the Study:

  • To investigate the induction of hepatic antioxidant genes by 3H-1,2-dithiole-3-thione (D3T).
  • To explore the role of D3T in regulating antioxidant enzyme expression and activity.

Main Methods:

  • Rats were treated with D3T, and hepatic gene expression, protein levels, and enzyme activities were measured.
  • Nuclear run-on assays and promoter-reporter constructs were used to assess transcriptional regulation.

Main Results:

  • D3T increased catalase mRNA, protein, and activity.
  • Significant increases in manganese superoxide dismutase (MnSOD) mRNA, protein, and activity were observed.
  • D3T elevated gamma-glutamylcysteine synthetase mRNA and glutathione levels, enhancing gene transcription.

Conclusions:

  • D3T enhances the transcription of key antioxidant genes, including MnSOD, catalase, and gamma-glutamylcysteine synthetase.
  • This transcriptional induction of antioxidant enzymes is a potential mechanism for the chemoprotective effects of 1,2-dithiole-3-thiones.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...